Patrick J. Heron - Jul 20, 2021 Form 4 Insider Report for Imago BioSciences, Inc. (IMGO)

Role
Director
Signature
/s/ Patrick J. Heron
Stock symbol
IMGO
Transactions as of
Jul 20, 2021
Transactions value $
$3,000,000
Form type
4
Date filed
7/20/2021, 05:54 PM
Previous filing
Jul 15, 2021
Next filing
Jun 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGO Common Stock Purchase $665K +41.6K $16.00 41.6K Jul 20, 2021 See Footnote F1
transaction IMGO Common Stock Purchase $2.33M +146K $16.00 146K Jul 20, 2021 See Footnote F2
transaction IMGO Common Stock Conversion of derivative security +342K +822.31% 384K Jul 20, 2021 See Footnote F1, F3
transaction IMGO Common Stock Conversion of derivative security +211K +55.04% 595K Jul 20, 2021 See Footnote F1, F3
transaction IMGO Common Stock Conversion of derivative security +64.4K +10.82% 659K Jul 20, 2021 See Footnote F1, F3
transaction IMGO Common Stock Conversion of derivative security +1.2M +822.3% 1.35M Jul 20, 2021 See Footnote F2, F3
transaction IMGO Common Stock Conversion of derivative security +741K +55.04% 2.09M Jul 20, 2021 See Footnote F2, F3
transaction IMGO Common Stock Conversion of derivative security +226K +10.82% 2.31M Jul 20, 2021 See Footnote F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGO Series A Preferred Stock Conversion of derivative security $0 -342K -100% $0.00* 0 Jul 20, 2021 Common Stock 342K See Footnote F1, F3
transaction IMGO Series B Preferred Stock Conversion of derivative security $0 -211K -100% $0.00* 0 Jul 20, 2021 Common Stock 211K See Footnote F1, F3
transaction IMGO Series C Preferred Stock Conversion of derivative security $0 -64.4K -100% $0.00* 0 Jul 20, 2021 Common Stock 64.4K See Footnote F1, F3
transaction IMGO Series A Preferred Stock Conversion of derivative security $0 -1.2M -100% $0.00* 0 Jul 20, 2021 Common Stock 1.2M See Footnote F2, F3
transaction IMGO Series B Preferred Stock Conversion of derivative security $0 -741K -100% $0.00* 0 Jul 20, 2021 Common Stock 741K See Footnote F2, F3
transaction IMGO Series C Preferred Stock Conversion of derivative security $0 -226K -100% $0.00* 0 Jul 20, 2021 Common Stock 226K See Footnote F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held directly by Frazier Healthcare VII-A, L.P. ("FH VIIA"). The general partner of FH VIIA is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VIIA. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by FH VIIA, except to the extent of his or its pecuniary interest therein, if any.
F2 These shares are held directly by Frazier Healthcare VII, L.P. ("FH VII"). The general partner of FH VII is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VII. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by FH VII, except to the extent of his or its pecuniary interest therein, if any.
F3 Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date.